This truncating mutation was found in a Chinese woman who developed invasive ductal carcinoma at age 39, which was positive for the expression of both estrogen- and progesterone-receptors and had amplification of HER-2 receptor. The gene discussed is PGR; the disease is invasive ductal breast carcinoma.